Stock analysis, trade plans, and proprietary indicators by Trend Edge.
About iBio, Inc. Common Stock
iBio, Inc., a preclinical stage biotechnology company, engages in the development of artificial intelligence (AI) antibodies solutions for cardiometabolic and obesity space. The company's technology platforms include EngageTx that provides improved CD3 T-cell engager antibody panel; ShieldTx, an antibody masking technology that enables the creation of conditionally activated antibodies; StableHu, an AI antibody-optimizing technology; and AI epito… Read full Trend Edge analysis →
Sector: Healthcare
Industry: Biotechnology
Exchange: NASDAQ
IPO Date: August 19, 2008
Headquarters: 11750 Sorrento Valley Road, San Diego, CA, United States, 92121
Trend Edge tracks near-term, medium-term, cyclical, and secular moving averages across weekly and monthly timeframes to identify trend structure at every horizon.
Timeframe
SMA
Value
Trend Context
Weekly
10-Week SMA
$1.81
Near-term / short-term trend
Weekly
40-Week SMA
$1.69
Medium-term trend
Weekly
80-Week SMA
$1.91
Cyclical trend (business cycle)
Weekly
200-Week SMA
$13.57
Secular trend (multi-year)
Monthly
10-Month SMA
$1.68
Near-term monthly trend
Monthly
20-Month SMA
$2.05
Medium-term monthly trend
Monthly
40-Month SMA
$5.17
Secular monthly trend
Volume Shelves — Support & Resistance
Trend Edge identifies volume shelves: price zones where historically elevated trading volume
creates structural support or resistance. A volume shelf forms when a disproportionate share of cumulative
volume was transacted at a specific price level, making it a high-conviction anchor for future price reactions.
Price Level
Type
Volume Ratio
Age
$1.20
support
3.88x
4 months ago
$0.90
support
3.80x
6 months ago
$4.00
resistance
4.94x
12 months ago
$5.70
resistance
2.45x
13 months ago
Historical Earnings Reactions (64 events)
Timeframe
Avg Return
Median
Win Rate
Best
Worst
Gap
-1.12%
-0.27%
29.69%
20.29%
-37.50%
1 Day
-2.07%
-1.69%
23.44%
23.33%
-34.38%
1 Week
-2.25%
-2.27%
39.06%
43.08%
-46.88%
2 Weeks
7.67%
0.00%
48.44%
481.58%
-69.63%
1 Month
5.41%
-3.39%
42.86%
321.05%
-77.76%
Next earnings: July 31, 2026 (62 days away)
Seasonality & Day-of-Week Patterns
Monthly Seasonality
Month
Avg Return
Win Rate
Samples
Jan
19.2%
66.7%
18
Feb
60.3%
55.6%
18
Mar
12.2%
44.4%
18
Apr
-4.0%
27.8%
18
May
-6.6%
35.3%
17
Jun
2.6%
52.9%
17
Jul
3.6%
29.4%
17
Aug
1.1%
41.2%
17
Sep
-3.9%
38.9%
18
Oct
-2.9%
22.2%
18
Nov
-12.4%
33.3%
18
Dec
-13.2%
16.7%
18
Day-of-Week Tendencies
Day
Avg Return
Win Rate
Samples
Monday
-0.04%
33.8%
837
Tuesday
-0.39%
33.7%
920
Wednesday
0.62%
36.6%
917
Thursday
0.11%
37.5%
898
Friday
0.81%
39.6%
896
Top Institutional Holders
Institutional holder breakdown coming soon.
Total institutional ownership: 46.9%
Insider Transactions — Smart Summary
Total insider ownership: 1.7%
12-Month Insider Activity Summary
Total Filings
3
Net Value
+$98,105.847
Net Shares Change
51,105
% of Float
0.1%
C-Suite Filings
3
Clusters Detected
1
Key Insiders
Name
Title
Net Value
Filings
Activity
Duran Felipe
Chief Financial Officer
+$50,131.931
1
1 buy
Brenner Martin
Chief Executive Officer and Chief Scientific Officer
+$24,918.72
1
1 buy
Banjak Marc
Chief Legal Officer
+$23,055.196
1
1 buy
Transaction Clusters
Period
Filings
Insiders
Net Value
Seniority
2026-03-23 – 2026-03-27
3
3
+$98,105.847
3 C-suite
Significant Filings
Date
Insider
Title
Net Value
Price After
2026-03-27
Banjak Marc
Chief Legal Officer
+$23,055.196
Transaction at $1.65, now +14.8%
2026-03-23
Duran Felipe
Chief Financial Officer
+$50,131.931
Transaction at $2.02, now -5.9%
2026-03-23
Brenner Martin
Chief Executive Officer and Chief Scientific Officer
Trend Edge's AI Consult feature delivers a comprehensive, multi-layer trade plan for iBio, Inc. Common Stock
(IBIO) powered by Claude Opus — Anthropic's most capable AI model.
The analysis covers five layers:
technical analysis (near-term, medium-term, cyclical, and secular trend, momentum,
volume shelf support and resistance, breakout and breakdown signals),
qualitative analysis (business model, competitive moat, sector dynamics),
insider sentiment (buy and sell signals from executive and director transactions),
share stats analysis (institutional accumulation, fund positioning, short float squeeze potential), and
fundamental analysis (valuation, revenue growth, profit margin, earnings quality).
AI Consult synthesizes all five layers into a single bullish or bearish thesis with explicit entry, exit,
stop loss, and take profit levels — giving you a complete, AI-powered trade plan with defined risk/reward.
Whether you are building a long position, initiating a short, or looking for a reversal setup,
AI Consult identifies the highest-probability signal from the current trend.